Literature DB >> 19939646

Hydroxyapatite particles as drug carriers for proteins.

Keishiro Tomoda1, Hidehiko Ariizumi, Takatomo Nakaji, Kimiko Makino.   

Abstract

Recently, much attention has been paid to hydroxyapatite (HA) particles as protein drug carriers. HA is biological substance like tooth and bone, and HA has biodegradable and biocompatible property. Also HA has high affinity for versatile substances, such as proteins. The aim of this study was to prepare HA particles and to evaluate the effects of various experimental conditions on particles properties (i.e. shape and amount of protein adsorption to HA). HA particles were prepared by three methods including solvent diffusion methods, the method using sintering porous HA microgranules, and homogeneous precipitation method. Complicated spiky crystals were prepared by solvent diffusion method, whereas spherical amorphous agglomerates were prepared by sintering of porous HA granules. Spherical particles were obtained by homogeneous precipitation method and were well dispersed. The spherical particles were composed of minute spiky crystals. The temperature and time duration of the producing process and the amount of additives, such as urea and EDTANa(2), strongly affected the particle shape and size. When the production process is kept under low temperature, tiny crystals were not mutually sintered and also their aggregation was not deposited. Also, inhomogeneous crystal growth occurred when the reaction time was long. Addition of enough amount of EDTANa(2) to reaction solution made the small and spherical HA particles. Bovine serum albumin (BSA) or lysozyme hydrochloride (LSZ)-adsorbed HA particles were prepared. The affinity of HA particles and release profile of proteins from the particles were evaluated. X-ray powder diffraction measurements suggested that the surface area ratio of a plane against total surface area of HA crystal became smaller by decreasing EDTANa(2) concentration. The surface of plane a is positively charged but that of plane c is negatively charged. HA particle size decreased as EDTANa(2) concentration increased. The amounts of BSA and LSZ adsorbing onto HA particle surface were different, since BSA was negatively charged and LSZ was positively charged in the solution. Therefore BSA seems to adsorb onto plane c, whereas LSZ adsorb onto plane a. The differences of the ratio of surface a plane against the total surface area of HA particles and particles size influenced the amount of protein adsorption. The sustained release of BSA and LSZ from HA particles were observed for two weeks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939646     DOI: 10.1016/j.colsurfb.2009.10.039

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  6 in total

1.  Longgu (Fossilia Ossis Mastodi) alters the profiles of organic and inorganic components in Keishikaryukotsuboreito.

Authors:  Kazuki Oguri; Masaya Kawase; Kazuo Harada; Kayoko Shimada-Takaura; Toshiharu Takahashi; Kyoko Takahashi
Journal:  J Nat Med       Date:  2016-02-03       Impact factor: 2.343

Review 2.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

3.  Adsorption and desorption of bioactive proteins on hydroxyapatite for protein delivery systems.

Authors:  Chie Kojima; Kenji Watanabe
Journal:  J Drug Deliv       Date:  2012-03-05

4.  Calcium orthophosphates as bioceramics: state of the art.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2010-11-30

5.  Microstructural, electrical and biological activity in [Formula: see text] ceramic composites designed for tissue engineering applications.

Authors:  Apurba Das; Pamu Dobbidi; Aman Bhardwaj; Varun Saxena; Lalit M Pandey
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

Review 6.  Synthesis of spherical calcium phosphate particles for dental and orthopedic applications.

Authors:  Marc Bohner; Solène Tadier; Noémie van Garderen; Alex de Gasparo; Nicola Döbelin; Gamal Baroud
Journal:  Biomatter       Date:  2013-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.